ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $80,000 | +1.3% | 12,200 | 0.0% | 0.02% | +17.6% |
| Q2 2022 | $79,000 | -30.1% | 12,200 | -50.0% | 0.02% | -22.7% |
| Q1 2022 | $113,000 | +79.4% | 24,400 | +100.0% | 0.02% | +100.0% |
| Q4 2021 | $63,000 | -49.6% | 12,200 | 0.0% | 0.01% | -52.2% |
| Q3 2021 | $125,000 | -48.3% | 12,200 | 0.0% | 0.02% | -51.1% |
| Q2 2021 | $242,000 | -28.0% | 12,200 | 0.0% | 0.05% | -33.8% |
| Q1 2021 | $336,000 | +2.4% | 12,200 | 0.0% | 0.07% | -5.3% |
| Q4 2020 | $328,000 | – | 12,200 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |